VRC 200: A Multicenter Specimen Collection Protocol to Obtain Human Biological Samples for Research Studies

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

This study collects specimens from volunteers for use in studies by NIAID's Vaccine Research Center. A number of different types of specimens or samples can be collected, including blood, urine, body fluids or secretions, skin swabs, or skin biopsies. The samples are used for medical research, including the study of HIV, hepatitis, and other diseases; immune system responses, such as responses to vaccinations or infections; and for research on vaccine development. Blood samples may be collected either by ordinary blood drawing (phlebotomy) or by apheresis, a procedure for collecting a larger quantity of blood cells or plasma than would be possible through simple blood drawing. For this procedure, the participant lies on a recliner or couch. Blood is removed through a needle in the vein of one arm and spun in a machine that separates out the desired component (plasma or white blood cells). The remainder of the blood is returned either through the same needle or through a needle in the other arm. The procedure takes about 1 to 3 hours. Volunteers who are 18 years of age and older, including participants in other NIH research protocols, may be eligible. Individuals who have a condition that the research staff considers a reason not to make a sample donation will be excluded from the study. Participants may have only one sample collected or may be asked to undergo repetitive sample collection procedures, depending upon the requirements of the particular research project for which the samples are being collected. Each individual's enrollment is for a 1-year period, which can be extended. ...

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ A participant must meet all the inclusion criteria, as follows:

• Age 18 years or older

• Able and willing to complete the informed consent process

• Willing to provide blood or other samples that will be stored indefinitely and used for future research

• Able to provide proof of identity to the acceptance of the clinician completing the enrollment process; when informed consent is obtained by telephone or a telehealth visit, the investigator obtaining consent will also confirm proof of identity.

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Washington
EvergreenHealth Medical Center
COMPLETED
Kirkland
Other Locations
Puerto Rico
University of Puerto Rico Medical Sciences Campus
ACTIVE_NOT_RECRUITING
San Juan
Contact Information
Primary
OPS Team, VRC
vaccines@nih.gov
Not Listed
Time Frame
Start Date: 2003-09-10
Participants
Target number of participants: 3000
Treatments
1
Sample collection only
Authors
Grace L Chen, Martin R Gaudinski
Related Therapeutic Areas
Sponsors
Leads: National Institute of Allergy and Infectious Diseases (NIAID)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials